Celanese (CE)
(Delayed Data from NYSE)
$126.40 USD
+1.36 (1.09%)
Updated Aug 8, 2024 04:00 PM ET
After-Market: $126.44 +0.04 (0.03%) 7:58 PM ET
4-Sell of 5 4
B Value D Growth D Momentum C VGM
Brokerage Reports
Celanese Corporation [CE]
Reports for Purchase
Showing records 81 - 100 ( 474 total )
Company: Celanese Corporation
Industry: Chemical - Diversified
2Q22 First Look - Strong Results, but We See Risks to 2H Guidance
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
Outlining Financing for Acquisition of DD M&M
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
M&M EBITDA Tracking Below $900M Target So Far
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
1Q22 Follow-Up - Price/Cost and Demand Improve, While Acetyls Stays Strong
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
1Q22 First Look - FY22 Guidance Raised 15% Above Consensus
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
Chemicals: 1Q22 Preview - Demand Is at Cycle Peak, but Some Commodities Could Work, We Believe
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department